OncoLens Closes $1.35M Seed Funding Round

oncolensOncoLens, an Atlanta, GA-based technology company serving cancer care programs, closed a $1.35m seed funding round.

BIP Capital and Atlanta Technology Angels (ATA) led the round. As part of this funding round, OncoLens announced Sarath Degala, vice president at BIP Capital, and ATA board member Bill Midgette have joined its board of directors.

The company will deploy the capital toward its strategic growth plans.

Led by Anju Mathew, CEO and co-founder, OncoLens provides a platform that enables a diverse and multispecialty cancer care team to collaborate on treatment plans for individual patients. The company also provides cancer-specific decision support and assists cancer programs to track, discuss and implement nationally approved quality metrics. It is part of Georgia Tech’s Advanced Technology Development Center’s ATDC Accelerate portfolio and in 2018.



Join the discussion